Tofacitinib

Tofacitinib
Tofacitinib

Tofacitinib

Min.Order / FOB Price:Get Latest Price

0 Metric Ton

Negotiable

  • Min.Order :0 Metric Ton
  • Purity: 99%
  • Payment Terms : L/C,D/P,T/T,Other

Keywords

Tofacitinib CAS.477600-75-2 Tofacitinib citrate

Quick Details

  • Appearance:
  • Application:Intermediate of Tofacitinib citrate in the treatment of Rheumatoid arthritis, Ulcerative colitis
  • PackAge:According the customers requirment
  • ProductionCapacity:|Metric Ton|Day
  • Storage:
  • Transportation:By Air/Sea/Express

Superiority:

Henan Wising Chem Co., Ltd is a national high-tech enterprise with a passion for selling and an emphasis on customer care.
 
We are committed to providing quality chemical products that help us become one of the most reputable, reliable and leading chemical products suppliers in the domestic and global markets.
 
We purpose to bring our value clients the best quality products, the most competitive prices, the shortest delivery and the best service.
 
Our customers include BASF, Bayer, Dupont, Sun Pharma, MSN Laboratories, Unither Pharmaceuticals, CAHIC, Cadila Healthcare, Hetero Drugs and Amgen in the US.
 
Wising Chem is a reliable distributor in domestic and global markets, we own an excellent reserch team based on Zhengzhou University, Shanghai Medical College of Fudan University and Henan University of Animal Husbandry&Economy, we focus on Pharmaceutical intermediates, raw materials and excipients, Vitamin(feed&food grade), and rare chemiclas.

Details:

CAS:477600-75-2

Molecular Formular:C16H20N6O

Molecular Weight:312.37

Description:Intermediate of Tofacitinib citrate in the treatment of Rheumatoid arthritis, Ulcerative colitis

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View